Monteris Medical
United States
- Minnetonka, MN
- 13/03/2026
- Series E
- $28,000,000
Monteris Medical is the manufacturer of the NeuroBlate® System, the only minimally invasive, robotic, laser interstitial thermal therapy (LITT) that uses MR-guided surgical ablation technology designed specifically for use in the brain. NeuroBlate is an advanced surgical tool designed for precise ablation of brain lesions including primary and metastatic brain tumors, radiation necrosis, and epileptogenic foci for those suffering from drug-resistant epilepsy. NeuroBlate is supported by a strong foundation of prospective multi-center clinical evidence. Patients undergoing a NeuroBlate procedure have demonstrated short hospital stays, minimal complications, and low hospital readmissions.
For full prescribing information, visit https://bit.ly/3pdAg6x. Rx Only.
- Industry Medical Equipment Manufacturing
- Website https://www.monteris.com/
- LinkedIn https://www.linkedin.com/company/monteris-medical/
Arycs Technologies | $24,000,000 | (Mar 13, 2026)
Ezra(2) | $8,000,000 | (Mar 13, 2026)
Freestyle | $10,000,000 | (Mar 13, 2026)
Gumloop | $50,000,000 | (Mar 13, 2026)
Combat Medical Ltd | $3,472,639 | (Mar 13, 2026)
Qurrent | $15,000,000 | (Mar 13, 2026)
Waiv, formerly Owkin Dx | $33,000,000 | (Mar 13, 2026)
Carefam | $14,500,000 | (Mar 13, 2026)
Option Circle | $3,000,000 | (Mar 12, 2026)
AgentMail (YC S25) | $6,000,000 | (Mar 12, 2026)